Darwin Global Management »

Geron Corporation shares owned by Darwin Global Management

Quarter-by-quarter ownership of Geron Corporation (GERN) shares owned by Darwin Global Management from 13F filings

Historical chart of Darwin Global Management investment in Geron Corporation

Tip: Access up to 7 years of quarterly data

All positions including Geron Corporation held by Darwin Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Geron Corporation by Darwin Global Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $106M 24M 4.44

More positions owned by Darwin Global Management

Cytokinetics Com New (CYTK)
Insmed Com Par $.01 (INSM)
Vaxcyte (PCVX)
Geron Corporation (GERN)
Keros Therapeutics (KROS)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Spyre Therapeutics Com New (SYRE)
Avidity Biosciences Ord (RNA)
Elevation Oncology (ELEV)

View all positions for Darwin Global Management

Top funds holding Geron Corporation

BlackRock
RA Capital Management
Vanguard Group
Darwin Global Management
State Street Corporation
Leucadia National Corporation
Woodline Partners
Farallon Capital Management
Deep Track Capital
Geode Capital Management
Goldman Sachs Group
T. Rowe Price Associates
OrbiMed Advisors
Henderson Group
Millennium Management

View all funds holding Geron Corporation